Littérature scientifique sur le sujet « Carbonyl reductase 1 (CBR1) »
Créez une référence correcte selon les styles APA, MLA, Chicago, Harvard et plusieurs autres
Consultez les listes thématiques d’articles de revues, de livres, de thèses, de rapports de conférences et d’autres sources académiques sur le sujet « Carbonyl reductase 1 (CBR1) ».
À côté de chaque source dans la liste de références il y a un bouton « Ajouter à la bibliographie ». Cliquez sur ce bouton, et nous générerons automatiquement la référence bibliographique pour la source choisie selon votre style de citation préféré : APA, MLA, Harvard, Vancouver, Chicago, etc.
Vous pouvez aussi télécharger le texte intégral de la publication scolaire au format pdf et consulter son résumé en ligne lorsque ces informations sont inclues dans les métadonnées.
Articles de revues sur le sujet "Carbonyl reductase 1 (CBR1)"
Varatharajan, Savitha, Ajay Abraham, Shaji R. Velayudhan, Rayaz Ahmed, Aby Abraham, Biju George, Mammen Chandy, Alok Srivastava, Vikram Mathews et Poonkuzhali Balasubramanian. « Carbonyl Reductase 1 Expression and Polymorphisms Influence Daunorubicin Metabolism in AML ». Blood 118, no 21 (18 novembre 2011) : 2484. http://dx.doi.org/10.1182/blood.v118.21.2484.2484.
Texte intégralBlanco, Javier G., Can-Lan Sun, Wendy Landier, Lu Chen, Diego Esparza-Duran, Wendy Leisenring, Allison Mays et al. « Anthracycline-Related Cardiomyopathy After Childhood Cancer : Role of Polymorphisms in Carbonyl Reductase Genes—A Report From the Children's Oncology Group ». Journal of Clinical Oncology 30, no 13 (1 mai 2012) : 1415–21. http://dx.doi.org/10.1200/jco.2011.34.8987.
Texte intégralHu, Dawei, Namiki Miyagi, Yuki Arai, Hiroaki Oguri, Takeshi Miura, Toru Nishinaka, Tomoyuki Terada et al. « Synthesis of 8-hydroxy-2-iminochromene derivatives as selective and potent inhibitors of human carbonyl reductase 1 ». Organic & ; Biomolecular Chemistry 13, no 27 (2015) : 7487–99. http://dx.doi.org/10.1039/c5ob00847f.
Texte intégralVyskočilová, Erika, Barbora Szotáková, Lenka Skálová, Hana Bártíková, Jitka Hlaváčová et Iva Boušová. « Age-Related Changes in Hepatic Activity and Expression of Detoxification Enzymes in Male Rats ». BioMed Research International 2013 (2013) : 1–10. http://dx.doi.org/10.1155/2013/408573.
Texte intégralBell, Rachel, Elisa Villalobos, Mark Nixon, Allende Miguelez-Crespo, Matthew Sharp, Martha Koerner, Emma Allan et al. « Carbonyl Reductase 1 Overexpression in Adipose Amplifies Local Glucocorticoid Action and Impairs Glucose Tolerance in Lean Mice ». Journal of the Endocrine Society 5, Supplement_1 (1 mai 2021) : A806. http://dx.doi.org/10.1210/jendso/bvab048.1639.
Texte intégralWaclawik, Agnieszka, et Adam J. Ziecik. « Differential expression of prostaglandin (PG) synthesis enzymes in conceptus during peri-implantation period and endometrial expression of carbonyl reductase/PG 9-ketoreductase in the pig ». Journal of Endocrinology 194, no 3 (septembre 2007) : 499–510. http://dx.doi.org/10.1677/joe-07-0155.
Texte intégralGuo, Chunming, Wangsheng Wang, Chao Liu, Leslie Myatt et Kang Sun. « Induction of PGF2α Synthesis by Cortisol Through GR Dependent Induction of CBR1 in Human Amnion Fibroblasts ». Endocrinology 155, no 8 (1 août 2014) : 3017–24. http://dx.doi.org/10.1210/en.2013-1848.
Texte intégralFerguson, Daniel C., Qiuying Cheng et Javier G. Blanco. « Characterization of the Canine Anthracycline-Metabolizing Enzyme Carbonyl Reductase 1 (cbr1) and the Functional Isoform cbr1 V218 ». Drug Metabolism and Disposition 43, no 7 (27 avril 2015) : 922–27. http://dx.doi.org/10.1124/dmd.115.064295.
Texte intégralMadadi Mahani, Nosrat, Alireaza Mohadesi Zarandi et Azra Horzadeh. « QSAR studies of novel iminochromene derivatives as as carbonyl reductase 1 (CBR1) inhibito ». Marmara Pharmaceutical Journal 22, no 2 (6 avril 2018) : 227–36. http://dx.doi.org/10.12991/mpj.2018.60.
Texte intégralMiura, Takeshi, Ayako Taketomi, Toru Nishinaka et Tomoyuki Terada. « Regulation of human carbonyl reductase 1 (CBR1, SDR21C1) gene by transcription factor Nrf2 ». Chemico-Biological Interactions 202, no 1-3 (février 2013) : 126–35. http://dx.doi.org/10.1016/j.cbi.2012.11.023.
Texte intégralThèses sur le sujet "Carbonyl reductase 1 (CBR1)"
ROTONDO, ROSSELLA. « New enzymatic pathway(s) in 4-hydroxynonenal metabolism ». Doctoral thesis, Università di Siena, 2017. http://hdl.handle.net/11365/1007903.
Texte intégralKlafke, Jonatas Zeni. « Efeitos da Campomanesia xanthocarpa em parâmetros bioquímicos, hematológicos e de estresse oxidativo em pacientes hipercolestrolêmicos ». Universidade Federal de Santa Maria, 2009. http://repositorio.ufsm.br/handle/1/11116.
Texte intégralIn Southern Brazil, the plant Campomanesia xanthocarpa Berg. (Myrtaceae), popularly known as guavirova , has been empirically used for its potential effect in reducing blood cholesterol levels. Since there are no scientific data confirming its popular use, the aim of the present study was to investigate the effect of C. xanthocarpa on biochemical, hematological, anthropometrical and oxidative stress parameters in hypercholesterolemic patients. Thirty three patients were selected according to total cholesterol (TC) levels: 200-240 mg/dL, undesirable level (UL), and >240 mg/dL, hypercholesterolemic level (HL). UL or HL patients were randomly divided into control group (CG), which received placebo capsules, and experimental group 250 (EG 250) or 500 (EG 500), which received either 250 or 500 mg of encapsulated C. xanthocarpa. All groups received a cholesterol restriction diet and capsules once a day. The biochemical (TC, triglycerides, HDL, LDL and VLDL), hematological (hematocrit and hemoglobin), anthropometrical (weight and abdominal circumference) and oxidative stress (protein carbonyl) parameters were measured before, 45 and 90 days after the treatment started. There was no alteration on biochemical, hematological, anthropometric or oxidative stress parameters in UL patients of all groups. However, a significant decrease in TC and LDL levels was observed in HL patients from EG 500 group (reduction of 28±3 and 45±4% to levels before treatment) in relation to CG group patients (reduction of 12±2 and 29±4%). Moreover, a significant reduction in oxidative stress was observed in HL patients of EG 250 (51±12%) and EG 500 groups (34±18%) when compared to levels before treatment. A positive correlation between plasma oxidative stress PC and TC levels was observed. Finally, was demonstrated that C. xanthocarpa extract possesses anti-oxidant properties and 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitory activity in vitro. Confirming its popular use, the treatment with C. xanthocarpa encapsulated reduced blood TC and LDL levels in hypercholesterolemic patients. Besides its effect on cholesterol levels, this plant reduced the oxidative stress in plasma of hypercholesterolemic patients as well.
No Sul do Brasil, a planta Campomanesia xanthocarpa Berg. (Myrtaceae), popularmente conhecida como guavirova , tem sido empiricamente usada por seu efeito potencial em reduzir os níveis de colesterol sanguíneo. Uma vez que não há dados científicos confirmando seu uso popular, o alvo do presente estudo foi investigar os efeitos da C. xanthocarpa nos parâmetros bioquímicos, hematológicos, antropométricos e de estresse oxidativo em pacientes hipercolesterolêmicos. Trinta e três pacientes foram selecionados de acordo com os níveis de colesterol total (CT): 200-240 mg/dL, níveis indesejáveis (NI), e > 240 mg/dL, níveis hipercolesterolêmicos (NH). Os pacientes NI e NH foram randomicamente divididos em grupo controle (GC), que recebeu cápsulas placebo, e grupo experimental 250 (GE 250) ou 500 (GE 500), que recebeu 250 ou 500 mg de C. xanthocarpa encapsulada. Todos os grupos receberam uma dieta com restrição a colesterol e cápsulas diariamente. Os parâmetros bioquímicos (CT, triacilgliceróis, HDL, LDL e VLDL), hematológicos (hematócrito e hemoglobina), antropométricos (peso e circunferência abdominal) e de estresse oxidativo (proteína carbonilada) foram mensurados antes, 45 e 90 dias depois do tratamento. Não houve nenhum alteração significativa nos parâmetros bioquímico, hematológico, antropométrico e de estresse oxidativo em pacientes NI de todos os grupos. Entretanto, uma redução significativa nos níveis de CT e LDL foi observada em pacientes NH do GE 500 (redução de 28±3 e 45±4% para os níveis antes do tratamento) em relação aos pacientes do GC (redução de 12±2 e 29±4%). Além disso, uma redução significante no estresse oxidativo foi observada em pacientes NH do GE 250 (51±12%) e GE 500 (34±18%) quando comparado com os níveis antes do tratamento. Uma correlação positiva entre os níveis de proteína carbonilada e CT foi observada. Finalmente, foi demonstrado que o extrato de C. xanthocarpa possui propriedade antioxidante e atividade inibitória da 3-hidroxi-3-metilglutaril coenzima A redutase in vitro. Confirmando seu uso popular, o tratamento com C. xanthocarpa reduziu os níveis de CT e LDL sanguíneos em pacientes hipercolesterolêmicos. Além dos seus efeitos nos níveis de colesterol, esta planta reduziu o estresse oxidativo no plasma de pacientes hipercolesterolêmicos.
Gonzalez, Covarrubias Mirelle Vanessa. « Pharmacogenetics of human carbonyl reductase 1 (CBR1) in liver from black and white donors ». 2008. http://proquest.umi.com/pqdweb?did=1597613551&sid=17&Fmt=2&clientId=39334&RQT=309&VName=PQD.
Texte intégralTitle from PDF title page (viewed on Feb. 11, 2009) Available through UMI ProQuest Digital Dissertations. Thesis adviser: Blanco, Javier G. Includes bibliographical references.
Livres sur le sujet "Carbonyl reductase 1 (CBR1)"
Henry, Weiner, dir. Enzymology and molecular biology of carbonyl metabolism 10 : Proceedings of the 10th Conference, Taos, New Mexico, July 1-5, 2000. Amsterdam : Elsevier, 2001.
Trouver le texte intégralGeoffrey, Flynn T., Weiner Henry et International Workshop on Aldehyde Dehydrogenase/Aldehyde Reductase/Alcohol Dehydrogenase (2nd : 1984 : Kingston, Ont.), dir. Enzymology of carbonyl metabolism 2 : Aldehyde dehydrogenase, aldo-keto reductase, and alcohol dehydrogenase : proceedings of an international workshop, held in Kingston, Ontario, Canada, July 1-4, 1984. New York : A.R. Liss, 1985.
Trouver le texte intégralChapitres de livres sur le sujet "Carbonyl reductase 1 (CBR1)"
Schaller, Micheline, et Bendicht Wermuth. « Rat Carbonyl Reductase ». Dans Advances in Experimental Medicine and Biology, 523–27. Boston, MA : Springer US, 1999. http://dx.doi.org/10.1007/978-1-4615-4735-8_66.
Texte intégralMizoguchi, Tadashi, Hiroyuki Itabe et Peter F. Kador. « Reactivity of Enzyme Modification Reagents with Aldose Reductase and Aldehyde Reductase ». Dans Enzymology and Molecular Biology of Carbonyl Metabolism 3, 205–16. Boston, MA : Springer US, 1990. http://dx.doi.org/10.1007/978-1-4684-5901-2_23.
Texte intégralWermuth, Bendicht. « Inhibition of Aldehyde Reductase by Carboxylic Acids ». Dans Enzymology and Molecular Biology of Carbonyl Metabolism 3, 197–204. Boston, MA : Springer US, 1990. http://dx.doi.org/10.1007/978-1-4684-5901-2_22.
Texte intégralNishimura, Chihiro, Yoshiharu Matsuura, Tsuyoshi Tanimoto, Takashi Yamaoka, Tai Akera et T. Geoffrey Flynn. « cDNA Cloning and Expression of Human Aldose Reductase ». Dans Enzymology and Molecular Biology of Carbonyl Metabolism 3, 119–27. Boston, MA : Springer US, 1990. http://dx.doi.org/10.1007/978-1-4684-5901-2_15.
Texte intégralHohman, Thomas C., Deborah Carper, Sarmila Dasgupta et Masayuki Kaneko. « Osmotic Stress Induces Aldose Reductase in Glomerular Endothelial Cells ». Dans Enzymology and Molecular Biology of Carbonyl Metabolism 3, 139–52. Boston, MA : Springer US, 1990. http://dx.doi.org/10.1007/978-1-4684-5901-2_17.
Texte intégralGrimshaw, Charles E. « A Kinetic Perspective on the Peculiarity of Aldose Reductase ». Dans Enzymology and Molecular Biology of Carbonyl Metabolism 3, 217–28. Boston, MA : Springer US, 1990. http://dx.doi.org/10.1007/978-1-4684-5901-2_24.
Texte intégralWermuth, Bendicht. « Expression of Human and Rat Carbonyl Reductase in E. Coli ». Dans Advances in Experimental Medicine and Biology, 203–9. Boston, MA : Springer US, 1995. http://dx.doi.org/10.1007/978-1-4615-1965-2_26.
Texte intégralCarper, Deborah, Sanai Sato, Susan Old, Stephen Chung et Peter F. Kador. « In Vitro Expression of Human Placental Aldose Reductase in Escherichia Coli ». Dans Enzymology and Molecular Biology of Carbonyl Metabolism 3, 129–38. Boston, MA : Springer US, 1990. http://dx.doi.org/10.1007/978-1-4684-5901-2_16.
Texte intégralRondeau, Jean-Michel, Dino Moras, Frédérique Tête, Alberto Podjarny, Alain Van Dorsselaer, Jean-Marc Reymann, Patrick Barth et Jean-François Biellmann. « Structural Studies of Pig Lens Aldose Reductase : Reversible Dimerization of the Enzyme ». Dans Enzymology and Molecular Biology of Carbonyl Metabolism 3, 113–18. Boston, MA : Springer US, 1990. http://dx.doi.org/10.1007/978-1-4684-5901-2_14.
Texte intégralMaser, Edmund, et Udo C. T. Oppermann. « Molecular Cloning and Sequencing of Mouse Hepatic 11ß-Hydroxysteroid Dehydrogenase/Carbonyl Reductase ». Dans Advances in Experimental Medicine and Biology, 211–21. Boston, MA : Springer US, 1995. http://dx.doi.org/10.1007/978-1-4615-1965-2_27.
Texte intégralActes de conférences sur le sujet "Carbonyl reductase 1 (CBR1)"
Marozkina, Nadzeya, W. G. Teague, Denise Thompson-Batt, Serpil C. Erzurum et Benjamin Gaston. « Carbonyl Reductase 1 Expression And Activity Are Increased In Human Asthma ». Dans American Thoracic Society 2011 International Conference, May 13-18, 2011 • Denver Colorado. American Thoracic Society, 2011. http://dx.doi.org/10.1164/ajrccm-conference.2011.183.1_meetingabstracts.a2066.
Texte intégral